Results of Rights Issue

Amlin PLC
28 November 2005


PRESS RELEASE
To be released 7am
28 November 2005


                                   Amlin plc

                             Result of Rights Issue


Amlin plc (the 'Company') announces that its Rights Issue closed at 11am on
Friday 25 November 2005 and is pleased to announce that it has received valid
acceptances in respect of 123,350,812 New Ordinary Shares, representing
approximately 96.51 per cent of the total number of 127,805,073 New Ordinary
Shares offered pursuant to the 7 for 22 fully underwritten Rights Issue
announced by the Company on 1 November 2005.



In accordance with the terms of the Underwriting Agreement dated 1 November 2005
between the Company and Hoare Govett, Hoare Govett will seek to procure
subscribers for the remaining 4,454,261 New Ordinary Shares for which valid
acceptances were not received.



Definitions used in the Prospectus dated 2 November 2005 shall have the same
meanings when used in this announcement, unless the context requires otherwise.


28 November 2005

                                     -Ends-


Enquiries:


Charles Pender, Amlin plc                      020 7746 1000
David Haggie, Haggie Financial                 020 7417 8989
Peter Rigby, Haggie Financial                  020 7417 8989



Hoare Govett Limited, which is authorised and regulated in the United Kingdom by
the Financial Services Authority, is acting as sponsor, underwriter, broker and
joint financial adviser to Amlin in connection with the Rights Issue and the
listing of the  New Ordinary Shares on the Official List and their admission to
trading on the London Stock Exchange's market for listed securities and will not
be responsible to anyone other than Amlin for providing the protections afforded
to clients of Hoare Govett Limited or for providing advice in relation to the
Rights Issue, proposed listing or admission to trading or the contents of this
announcement or any other matters referred to in this announcement.



Lexicon Partners Limited, which is authorised and regulated in the United
Kingdom by the Financial Services Authority, is acting as joint financial
adviser to Amlin in connection with the Rights Issue and the listing of the New
Ordinary Shares on the Official List and their admission to trading on the
London Stock Exchange's market for listed securities and will not be responsible
to anyone other than Amlin for providing the protections afforded to customers
of Lexicon Partners Limited or for providing advice in relation to the Rights
Issue, proposed listing or admission to trading or contents of this announcement
or any other matters referred to in this announcement.



The release, publication or distribution of this announcement in certain
jurisdictions may be restricted by law and therefore persons in such
jurisdictions into which this announcement is released, published or distributed
should inform themselves about and observe such restrictions.



No offer, invitation or inducement to acquire shares or other securities in
Amlin is being made by or in connection with this announcement. Any offer,
invitation or inducement to acquire shares in Amlin will be made solely by means
of the prospectus published on 2 November 2005, and any decision to keep, buy or
sell shares in Amlin should be made solely on the basis of the information
contained in such document.



This announcement is not for distribution or transmission, directly or
indirectly, in or into the United States, Canada, Australia, Japan, New Zealand
or the Republic of South Africa and does not constitute, or form part of, an
offer to sell or the solicitation of an offer to subscribe for or buy any
securities ('Securities'), nor the solicitation of any vote or approval in any
jurisdiction, nor shall there be any sale, issue or transfer of the Securities
referred to in this announcement in any jurisdiction in contravention of
applicable law.



The Securities have not been and will not be registered under the US Securities
Act of 1933, as amended (the 'Securities Act') and may not be offered or sold in
the United States unless registered under the Securities Act or an exemption
from such registration is available. No public offering of Securities of Amlin
is being made in the United States.






                      This information is provided by RNS
            The company news service from the London Stock Exchange